Latest Market Research Reports

  Immunohistochemistry has become an essential diagnostic technique in modern pathology laboratories due to its ability to detect specific antigens within tissue samples using targeted antibodies. The technology plays a critical role in cancer diagnosis, infectious disease detection, biomarker identification, and precision medicine applications. Healthcare providers and research institutions are increasingly relying on immunohistochemistry solutions to improve diagnostic accuracy and treatment planning. Advancements in digital pathology, artificial intelligence, automation platforms, and biomarker discovery are significantly transforming the immunohistochemistry landscape. Laboratories are adopting advanced staining systems, automated slide processing technologies, and AI assisted image analysis tools to improve efficiency and reduce diagnostic variability. The global  immunohistochemistry market  size was estimated at USD 2.40 billion in 2024 and is projected to reach US...

Immunohistochemistry Industry Overview The global immunohistochemistry market size was valued at USD 1.89 billion in 2021 and is expected to grow at a compound annual growth rate (CAGR) of 8.4% from 2022 to 2030.  Increasing implementation of automation and machine learning in IHC, coupled with the introduction of technologically advanced Immunohistochemistry (IHC) solutions, is expected to significantly drive the market over the forecast period. Advancements in IHC protocols have boosted its demand to a significant level in disease diagnosis. In addition, the rise in product approvals and the launch of technologically advanced IHC systems for disease diagnosis are further propelling the market growth. Gather more insights about the market drivers, restrains and growth of the Global Immunohistochemistry Market For instance, in August 2021, the FDA approved Roche’s VENTANA MMR RxDx Panel to identify dMMR solid tumor patients eligible for anti-PD-1 immunotherapy. Companies...